FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and represents gel-forming mixed dextran esters containing phosphate and carbamate groups of general formula: {C6H7O2(OH)3-x-y{[(OP(O)ONa)mONa)]xl[(O2P(O)ONa)k]x2}x(OCONH2)y}n, wherein x=x1+x2 is a degree of substitution in phosphate groups (mono- and diesters), x=0.47-1.09; X1 is a degree of substitution in monoesters, X1=0.01-0.48; m is a number of phosphates in monoesters, m=1-2; x2 is a degree of substitution in diesters, x2=0.01-1.09; k is a number of phosphates in diesters, k=1-2; y is a degree of substitution in carbamate groups, y=0.39-1.23; n is a degree of polymerisation, 20≥n≤1000.
EFFECT: invention provides producing low-toxic low- and high-substituted dextran phosphates in the form of hydrogels containing additionally carbamate groups and possessing antiproliferative activity with respect to cancer cells.
2 cl, 3 dwg, 14 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING GEL-FORMING DEXTRANE PHOSPHATES | 2010 |
|
RU2455007C1 |
HYDROGEL ANTICANCER MEDICAMENT | 2010 |
|
RU2442586C1 |
SOLID-PHASE METHOD FOR OBTAINING PHOSPHORYLATED HYALURONIC ACID FOR COSMETIC PURPOSES | 2021 |
|
RU2775654C1 |
COLLECTOR FOR FLOTATION OF CARBONATES | 2007 |
|
RU2454282C2 |
METHODS FOR PREPARING PHOSPHATE-ORGANIC COMPOUND, PHOSPHATE-ORGANIC COMPOUND AND DENTAL POLYMERIZING COMPOSITION BASED ON THEREOF | 2000 |
|
RU2241003C2 |
PREPARATION OF POLYFUNCTIONAL SULPHATED CELLULOSE POWDER DERIVATIVES EXHIBITING ANTICOAGULANT ACTIVITY | 2009 |
|
RU2430729C2 |
OILY ADDITIVE FOR COMBUSTIBLES | 1998 |
|
RU2167919C1 |
COMPLEX ETHER OF CELLULOSE, SIMULTANEOUSLY CONTAINING SULPHATE AND PHOSPHATE GROUPS AND METHOD OF PRODUCING SAID ETHER | 2008 |
|
RU2395524C2 |
PROCESS FOR PRODUCING MIXTURE OF MONO- AND DIALKYL-PHOSPHATES OF ALKALI METALS | 0 |
|
SU943242A1 |
METHOD OF OBTAINING FUNCTIONALISED DERIVATIVES OF HYALURONIC ACID AND FORMATION OF THEIR HYDROGELS | 2009 |
|
RU2523182C2 |
Authors
Dates
2012-12-10—Published
2010-11-01—Filed